MedTrace Logo

Kinesiophobia in Patients With Implanted Left Ventricular Assist Devices

NCT07394621 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2026-02-10

No results posted yet for this study

Summary

The goal of this prospective and cross-sectional observational study is to learn if the presence and changes in kinesiofobia (fear of movement) affect functional capacity levels in heart failure patients who are transplant candidates and have been implanted with a Left Ventricular Assist Device (LVAD). The main questions it aims to answer are:

i) Does the level of kinesiofobia change significantly 1 month after LVAD implantation? ii) Do changes in kinesiofobia levels predict changes in functional exercise capacity (measured by the 2-Minute Walk Test and 30-Second Sit-to-Stand Test)? Researchers will compare pre-discharge (baseline) measurements to 1-month post-discharge follow-up measurements to see if improvements in kinesiofobia correlate with improved functional mobility and endurance.

Participants will:

i) Complete the Tampa Scale of Kinesiofobia (TSK) to assess their fear of movement.

ii) Perform the 2-Minute Walk Test (2MWT) to evaluate functional exercise capacity and mobility.

iii) Perform the 30-Second Sit-to-Stand Test (30STS) to determine functional endurance and lower extremity performance.

iv) Receive standardized physical activity recommendations upon discharge. v) Return for a follow-up assessment one month later to repeat the same battery of tests.

Conditions

  • Kinesiophobia (Fear of Movement)

Interventions

DIAGNOSTIC_TEST

Physical Activity Recommandations

Patients with implanted LVADs will be given recommendations for physical activities they can incorporate into their daily lives.

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-02
Primary Completion
2026-01-04
Completion
2026-02-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07394621 on ClinicalTrials.gov